DOLYXAN 60 MG CPS ETD 28

What is the maximum co-payment for DOLYXAN?

If the insurance company contributes, the maximum co-payment is 413,68 Kč. The maximum pharmacy price is 566,72 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 378,72 Kč.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does DOLYXAN have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

153,04 Kč.

Does the insurance company pay a higher amount in some cases?

Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 188,00 Kč.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe DOLYXAN?

psychiatry, child and adolescent psychiatry, geriatric psychiatry
sexology
neurology, pediatric neurology

What is the composition of DOLYXAN?

Duloxetin-hydrochlorid (67,3 mg), duloxetin (60 mg), neznámá látka s kódem 14512, hypromelosa 2910, neznámá látka s kódem 17841, ointmentek, sacharosa, neznámá látka s kódem 16264, povidon, oxid titaničitý, indigokarmín, želatina, natrium-lauryl-sulfát, žlutý oxid železitý, neznámá látka s kódem 10256, neznámá látka s kódem 10258, makrogol 400, polysorbát 80, šelak, propylenglykol, hydroxid draselný. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to DOLYXAN?

The medicine belongs to ATC group N06AX21 – DULOXETIN. Medicines with the same active substance can be found here.

Who manufactures DOLYXAN?

BELUPO lijekovi i kozmetika, d.d., Koprivnica (CHO)

Is the medicine in shortage?

The latest report from the manufacturer is from 28. 7. 2025. Production was interrupted as of 28. 7. 2025. The stated reason was: Stažení šarže léčivého přípravku..
Resumption of supply is expected 5. 1. 2027
The manufacturer lists medicines with the following code as a potential substitute: